Kunyuan Wang
Overview
Explore the profile of Kunyuan Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang K, Gu C, Yu G, Lin J, Wang Z, Lu Q, et al.
Liver Res
. 2025 Feb;
6(3):167-174.
PMID: 39958198
Background And Aims: Berberine is one of the most promising clinically tested natural alkaloids, and immunotherapy using natural killer (NK) cells is a potentially effective treatment for hepatocellular carcinoma (HCC)....
2.
Lin X, Liu Z, Dong X, Wang K, Sun Y, Zhang H, et al.
J Transl Med
. 2024 Oct;
22(1):929.
PMID: 39396988
Background: Chimeric antigen receptor (CAR)-NK cell therapy has shown remarkable clinical efficacy and safety in the treatment of hematological malignancies. However, this efficacy was limited in solid tumors owing to...
3.
Wang H, Xie X, Du M, Wang X, Wang K, Chen X, et al.
Gene
. 2024 Sep;
933:148955.
PMID: 39303819
Background: Hepatocellular Carcinoma (HCC) is the most common digestive system malignancy, with unclear pathogenesis and low survival rates. AP1M2 is associated with tumor progression, but its role and molecular mechanisms...
4.
Wu Y, Han J, Zhang W, Yu Z, Wang K, Fang X, et al.
J Am Chem Soc
. 2024 Mar;
146(12):8086-8097.
PMID: 38479729
Achieving multiple high-value-added chemical production through novel reaction processes and shape-selective catalytic strategy is the key to realizing efficient low-carbon catalytic processes. In this work, a methanol-toluene coreaction system was...
5.
Wang K, Cui H, Zhu Y, Hu X, Hong C, Guo Y, et al.
BMC Cancer
. 2024 Feb;
24(1):246.
PMID: 38388861
Background: Artificial intelligence (AI)-assisted clinical trial screening is a promising prospect, although previous matching systems were developed in English, and relevant studies have only been conducted in Western countries. Therefore,...
6.
Wang K, Lu Q, Luo Y, Yu G, Wang Z, Lin J, et al.
Biol Direct
. 2024 Jan;
19(1):4.
PMID: 38163874
Background: Aberrant expression and activation of circular RNAs (circRNAs) are closely associated with various cancers. The role of circ_MAPK9 (hsa_circ_0001566) in cancer progression remains unknown. This study aims to investigate...
7.
Cheng X, Tang Y, He Q, Song J, Wang K, Li H, et al.
Aliment Pharmacol Ther
. 2023 Dec;
59(5):680-691.
PMID: 38155565
Background: Esophagogastroduodenoscopy (EGD) is required to screen for high-risk varices (HRV) in patients with hepatocellular carcinoma (HCC), especially since overall survival rates have dramatically improved with new systemic therapies. Aim:...
8.
Sun Q, Wang K, Chen Y, Peng X, Jiang X, Peng J
J Clin Nurs
. 2023 Oct;
33(2):497-530.
PMID: 37876319
Aims And Objective: To summarize evidence from systematic reviews (SRs)/meta-analyses (MAs) regarding the impact of dyadic interventions delivered to both members of a cancer dyad, including a cancer patient and...
9.
Ren X, Chen S, Wang K, Tan J
Math Biosci Eng
. 2022 Sep;
19(11):11422-11452.
PMID: 36124598
Swarm intelligence algorithms are relatively simple and highly applicable algorithms, especially for solving optimization problems with high reentrancy, high stochasticity, large scale, multi-objective and multi-constraint characteristics. The sparrow search algorithm...
10.
Sun Q, Jiang X, Qin R, Yang Y, Gong Y, Wang K, et al.
J Geriatr Oncol
. 2022 Jun;
13(7):924-934.
PMID: 35644850
Introduction: In the older patients with cancer, the combination of aging and cancer makes sarcopenia more likely to occur. However, previous studies paid less attention to the sarcopenia of older...